About FIRST ASCENT BIOMEDICAL INC.
First Ascent Biomedical provides rapid, personalized cancer treatment insights using a proprietary live-cell platform that tests up to 150+ FDA-approved therapies in parallel, delivering results in approximately 10 days or less.
Proprietary live-cell platform for testing up to 150+ FDA-approved therapies in parallelFunctional drug validation using live cancer cell response to drugs outside the bodyGenomic sequencing for identifying molecular markers through DNA and RNA sequencingAI cancer weakness mapping to pinpoint effective treatments based on unique cancer characteristicsDrug sensitivity testing and causal ML platform for accelerating drug development pipelines
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FIRST ASCENT BIOMEDICAL INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.